“Rockville, Maryland’s Autonomous Therapeutics (Autonomous) is a rapidly expanding biotech developing the next generation of antivirals and therapeutics. Founded four years ago in New York City by University of Maryland alum and Harvard-trained scientist, Ariel Weinberger, the company has expanded into an 18,000 square foot facility in Rockville, where it is growing its scientific and leadership team to support its pipeline of first-in-class therapeutics aimed at ending viral pandemics. […] ”
BioBuzz Interviews Autonomous Therapeutics CEO Ariel Weinberger
Previous
Previous
Autonomous CEO, Dr. Ariel Weinberger, presents on novel mRNA therapeutic technologies at the World Antiviral Congress
Next
Next